72P - The different prognostic impact of age according to individual molecular subtypes in breast cancer

Date 18 December 2016
Event ESMO Asia 2016 Congress
Session Poster lunch
Topics Breast Cancer, Early Stage
Cancer in Young Adults
Pathology/Molecular Biology
Presenter Yong Hwa Eom
Citation Annals of Oncology (2016) 27 (suppl_9): ix19-ix29. 10.1093/annonc/mdw575
Authors Y.H. Eom, B.J. Song, B.J. Chae, S.H. Yoo
  • Surgery, Seoul St. Mary's Hospital, of the Catholic University, 137-701 - Seoul/KR



Young age at diagnosis has been considered as a poor prognostic factor in breast cancer. But, it is unjust to consider that young age is the independent poor prognostic factor for all breast cancer. We analyzed the different prognostic impact of age according to molecular subtypes.


Our study retrieved data from 1,410 patients with primary breast cancer who underwent surgery and the adjuvant treatment between 2007 and 2011. The association of age and molecular subtypes with recurrence free survival(RFS) and disease specific survival(DSS) was assessed using Kaplan-Meier analysis, univariate and multivariate analysis.


Patients aged


Age at diagnosis of breast cancer had different role for prognosis according to molecular subtypes. Age itself is not the independent prognostic factor. Age

Clinical trial indentification

Legal entity responsible for the study





All authors have declared no conflicts of interest.